Here it is the Interview:
The announcement of UniQure’s AMT-130 gene therapy has been received with great interest but also with considerable confusion by families affected by Huntington’s disease.
Want to know more?
Listen to this interview, in simple language, and we hope accessible to the Spanish-speaking community.
Warm regards from Factor-H
On July 10, 2024, I wrote a reflection piece following the investor conference where uniQure presented the encouraging 24-month results
24/09/2025 Ignacio Muñoz-Sanjuan, neuroscientist and founder of the non-profit Factor-H, has expressed optimism that an experimental gene therapy for Huntington’s
On July 19, Factor H hosted a Medical Outreach event in San Luis, Venezuela, for people living with Huntington’s disease
English 
Español 
Português do Brasil